drugset / Trial / NCT01694706

Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir

NCT01694706

Phase 1 Completed 15 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of this trial is to investigate the effect of food and of gastric pH increase on the relative bioavailability of faldaprevir.

Timeline

Start
2012-09
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Faldaprevir Small molecule
Comparator Omeprazole Other / unclassified

Indications

No indication recorded.